Search

Ibrutinib improves survival in CLL and SLL patients: Results From the RESONATE Study.

Jun 13 2014 Posted in Press releases

Patients with chronic lymphoid leukemia (CLL) or small lymphocytic lymphoma (SLL) who experience short response duration or adverse cytogenetics have poor outcomes.

Sustainability

Actions we're taking to reduce the environmental impact of our flagship event: the EHA Congress.

Abstract & Clinical Case Submission

Abstract submission is an important part of the 7th European CAR T-cell Meeting.